TRXADE HEALTH, INC.
Trxade Health Email List: Click to Subscribe
View Company Website: Click to View
Market Data: Yahoo Finance, SEC Filings, Bloomberg
Report Link: Updated Research Note (Dated December, 13 2023)
Symbol: MEDS
Analyst: Howard Halpern
Taglich Rating: Suspended
Price Target: N/A
Time Horizon: N/A
Rating Established: September 12, 2023
Price When Established: $10.86
Most Recent Report: December 13, 2023
Price When Issued: $5.55
What’s New
New information will be posted soon…
Company Description
Trxade Health, Inc., headquartered in Tampa, Florida, is an integrated technology and services company focused on delivering an effective process for purchasing and delivering prescription drugs to independent pharmacies and consumers in the US. MEDS is developing a complete platform to make healthcare services affordable and accessible in the US through the integration of its existing Web-based trading platform, a licensed wholesaler, and its mobile telehealth service through the Bonum Health app and delivery capabilities. The company is developing the ability to provide healthcare services to patients without the patient leaving their home.
Company Reports
Updated Research Note (Dated December, 13 2023)
Updated Research Note (Dated September, 12 2023)
Updated Research Report (Dated May, 23 2023)
Updated Research Report (Dated April, 12 2023)
Updated Research Report (Dated November 14, 2022)
Updated Research Report (Dated August 2, 2022)
Updated Research Report (Dated May 17, 2022)
Updated Research Report (Dated April 1, 2022)
Updated Research Report (Dated November 1, 2021)
Updated Research Report (Dated August 2, 2021)
Updated Research Report (Dated May 3, 2021)
Updated Research Report (Dated April 5, 2021)
Updated Research Report (Dated November 2, 2020)